Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion type Assertion NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_head.
- NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_provenance.
- NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion evidence source_evidence_literature NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_provenance.
- NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion SIO_000772 11692073 NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_provenance.
- NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion wasDerivedFrom gad-20150221 NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_provenance.
- NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion wasGeneratedBy ECO_0000203 NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_provenance.